These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 22456601)

  • 1. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
    Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
    Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
    Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C3 glomerulopathy: what's in a name?
    D'Agati VD; Bomback AS
    Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
    Marinozzi MC; Chauvet S; Le Quintrec M; Mignotet M; Petitprez F; Legendre C; Cailliez M; Deschenes G; Fischbach M; Karras A; Nobili F; Pietrement C; Dragon-Durey MA; Fakhouri F; Roumenina LT; Fremeaux-Bacchi V
    Kidney Int; 2017 Nov; 92(5):1232-1241. PubMed ID: 28712854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.
    Leroy V; Fremeaux-Bacchi V; Peuchmaur M; Baudouin V; Deschênes G; Macher MA; Loirat C
    Pediatr Nephrol; 2011 Mar; 26(3):419-24. PubMed ID: 21188423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eculizumab for dense deposit disease and C3 glomerulonephritis.
    Bomback AS; Smith RJ; Barile GR; Zhang Y; Heher EC; Herlitz L; Stokes MB; Markowitz GS; D'Agati VD; Canetta PA; Radhakrishnan J; Appel GB
    Clin J Am Soc Nephrol; 2012 May; 7(5):748-56. PubMed ID: 22403278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
    Chen YY; Han SS; Cao Y; Yu XJ; Zhu L; Luo JC; Song WC; Yu F; Mao YH; Zhao MH
    Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
    Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
    J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining C3 glomerulopathy: 'C3 only' is a bridge too far.
    Larsen CP; Walker PD
    Kidney Int; 2013 Feb; 83(2):331-2. PubMed ID: 23364589
    [No Abstract]   [Full Text] [Related]  

  • 12. Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.
    Servais A; Noël LH; Dragon-Durey MA; Gübler MC; Rémy P; Buob D; Cordonnier C; Makdassi R; Jaber W; Boulanger E; Lesavre P; Frémeaux-Bacchi V
    Hum Pathol; 2011 Sep; 42(9):1305-11. PubMed ID: 21396679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
    Sethi S; Fervenza FC; Zhang Y; Nasr SH; Leung N; Vrana J; Cramer C; Nester CM; Smith RJ
    Clin J Am Soc Nephrol; 2011 May; 6(5):1009-17. PubMed ID: 21415311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.
    Noris M; Donadelli R; Remuzzi G
    Pediatr Nephrol; 2019 Aug; 34(8):1311-1323. PubMed ID: 29948306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes of alternative pathway dysregulation in dense deposit disease.
    Zhang Y; Meyer NC; Wang K; Nishimura C; Frees K; Jones M; Katz LM; Sethi S; Smith RJ
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):265-74. PubMed ID: 22223606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dense deposit disease and C3 glomerulopathy.
    Barbour TD; Pickering MC; Terence Cook H
    Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The authors reply:
    Servais A; Noel LH; Lesavre P; Frémeaux-Bacchi V
    Kidney Int; 2013 Feb; 83(2):332-3. PubMed ID: 23364592
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.
    Figuères ML; Frémeaux-Bacchi V; Rabant M; Galmiche L; Marinozzi MC; Grünfeld JP; Noël LH; Servais A
    Hum Pathol; 2014 Nov; 45(11):2326-33. PubMed ID: 25260719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy.
    Hawfield A; Iskandar SS; Smith RJ
    Am J Kidney Dis; 2013 May; 61(5):828-31. PubMed ID: 23391537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C3 glomerulopathy.
    Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
    Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.